VBI Vaccines Receives Positive CHMP Opinion for 3-Antigen Hepatitis B Vaccine

 - Following positive CHMP recommendation, final EMA regulatory decision expected in coming months

- European Union (EU) brand name to be PreHevbri™

- If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.

https://www.biospace.com/article/releases/vbi-vaccines-receives-positive-chmp-opinion-for-3-antigen-hepatitis-b-vaccine-for-immunization-against-hepatitis-b-infection-in-adults-in-the-european-union/